
Sanofi’s stock outlook has weakened as TD Cowen lowered its sales forecast for tolebrutinib
Source link
Neuralink plans ‘high-volume’ brain implant production by 2026, Musk said
Neuralink plans ‘high-volume’ brain implant production by 2026, Musk said Source link







